We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases.
- Authors
Kao, Johnny; Packer, Stuart; Ha Linh Vu; Schwartz, Myron E.; Sung, Max W.; Stock, Richard G.; Yeh-Chi Lo; Deiphine Huang; Shu-Hsia Chen; Cesaretti, Jamie A.
- Abstract
The article presents a clinical trial which investigates the safety and maximum-tolerated dose of a novel treatment combination of sunitinib and image-guided radiotherapy in oligometastatic patients. With a median follow-up of ten months, the results demonstrated the safety and efficacy of concurrent sunitinib and radiotherapy. It is indicated that sunitinib can be safely integrated into dose-intense protocols of image-guided radiotherapy at doses up to 37.5 milligram.
- Subjects
CLINICAL trials; RADIOTHERAPY; MEDICAL radiology; CANCER treatment; CLINICAL medicine research
- Publication
Cancer (0008543X), 2009, Vol 115, Issue 15, p3571
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.24412